Phase I clinical trial with a hexavalent PorA containing meningococcal outer membrane vesicle vaccine
- 1 July 1996
- Vol. 14 (10), 1009-1015
- https://doi.org/10.1016/0264-410x(96)00001-1
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Construction of Neisseria meningitidis strains carrying multiple chromosomal copies of the porA gene for use in the production of a multivalent outer membrane vesicle vaccineVaccine, 1995
- Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, BrazilThe Lancet, 1992
- Construction of a multivalent meningococcal vaccine strain based on the class 1 outer membrane proteinInfection and Immunity, 1992
- Effect of outer membrane vesicle vaccine against group B meningococcal disease in NorwayThe Lancet, 1991
- Topology of outer membrane porins in pathogenic Neisseria sppInfection and Immunity, 1991
- Isolation of Neisseria meningitidis mutants deficient in class 1 (porA) and class 3 (porB) outer membrane proteinsInfection and Immunity, 1990
- Comparative evaluation of potential components for group B meningococcal vaccine by passive protection in the infant rat and in vitro bactericidal assayVaccine, 1989
- Neisseria meningitidis group B serosubtyping using monoclonal antibodies in whole-cell ElisaMicrobial Pathogenesis, 1988
- Comparison of meningococcal outer membrane protein vaccines solubilized with detergent or C polysaccharideAntonie van Leeuwenhoek, 1987
- Serotype Antigens of Neisseria meningitidis and a Proposed Scbemefor Designation of SerotypesClinical Infectious Diseases, 1985